• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA VASCULAR COVERED STENT Back to Search Results
Catalog Number AVSM09100
Device Problem Misfire (2532)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/11/2023
Event Type  malfunction  
Event Description
It was reported that during a stent graft placement procedure, the stent was allegedly not fully deployed and was compacted.There was no reported patient injury.
 
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiry date: 01/2025).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Manufacturer Narrative
H10: manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the delivery system was not returned for evaluation and photos were provided which show a fully deployed stent in the vessel with a lying guidewire.The stent struts are not clearly visible such that strut evaluation is not possible but the radio-opaque markers or both ends of the stent can be seen.Contrasted blood can be seen in the vessel.The images cannot confirm the failure of a partial deployment.The investigation leads to inconclusive results for partial deployment.It was reported that the vessel was neither calcified nor tortuous, the lesion was pre-dilated and there was no noticeable damage to the device prior to use.Based on available information and as the sample was not returned, the investigation is closed with inconclusive results for partial deployment.A definite root cause for the reported event could not be found.Labeling review: in reviewing the relevant labeling for this product, the potential issue was found addressed.Based on the instruction for use supplied with this product delivery system specific events that could be associated with clinical complications include but are not limited to partial deployment and high deployment forces.With regards to accessories, the instruction for use states, use "0.035 inch guidewire of appropriate length to allow safe delivery of the covered stent and removal of the delivery system.Introducer sheath with appropriate inner diameter and length".Holding the device during deployment is found sufficiently described in the instruction for use.Regarding preparation the instruction for use states: "pre-dilate the stenosis with a pta balloon catheter of appropriate length and diameter for the lesion to be treated".H10: b5, d4 (expiry date: 01/2025), g3 h11: e1, h6 (method) h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported that during a stent graft placement procedure in the cephalic vein, the stent was allegedly not fully deployed and was compacted.There was no reported patient injury.
 
Manufacturer Narrative
H10: manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the delivery system was returned for evaluation in used condition, the covered stent was fully deployed and missing while the inner catheter was protruding the tip.The deployment mechanism is fully functional.Photos were provided which show a fully deployed stent in the vessel with a lying guidewire.The stent struts are not clearly visible such that strut evaluation is not possible but the radio-opaque markers or both ends of the stent can be seen.Contrasted blood can be seen in the vessel.The images cannot confirm the failure of a partial deployment.The investigation leads to inconclusive results for partial deployment.It was reported that the vessel was neither calcified nor tortuous, the lesion was pre-dilated and there was no noticeable damage to the device prior to use.Based on available information and the evaluation of the returned sample, the investigation is closed with inconclusive results for partial deployment.A definite root cause for the reported event could not be found.Labeling review: in reviewing the relevant labeling for this product, the potential issue was found addressed.Based on the instruction for use supplied with this product delivery system specific events that could be associated with clinical complications include but are not limited to partial deployment and high deployment forces.With regards to accessories, the instruction for use states, use "0.035 inch guidewire of appropriate length to allow safe delivery of the covered stent and removal of the delivery system.Introducer sheath with appropriate inner diameter and length".Holding the device during deployment is found sufficiently described in the instruction for use.Regarding preparation the instruction for use states: "pre-dilate the stenosis with a pta balloon catheter of appropriate length and diameter for the lesion to be treated".H10: d4 (expiry date: 01/2025), g3, h2, h6 (method).H11: section a through f the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that during a stent graft placement procedure in the cephalic vein, the stent was allegedly not fully deployed and was compacted.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVERA VASCULAR COVERED STENT
Type of Device
VASCULAR COVERED STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key17479553
MDR Text Key320596589
Report Number9681442-2023-00293
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741106361
UDI-Public(01)00801741106361
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P170042
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberAVSM09100
Device Lot NumberANHN1751
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/12/2023
Initial Date FDA Received08/08/2023
Supplement Dates Manufacturer Received08/25/2023
09/27/2023
Supplement Dates FDA Received08/30/2023
09/29/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-